• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SURGICEL POWDER USA - ABSORBABLE HEMOSTATIC PWDR; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SURGICEL POWDER USA - ABSORBABLE HEMOSTATIC PWDR; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED Back to Search Results
Model Number 3013SP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: what is the procedure name? =>no further information is available.What is the procedure date? =>no further information is available.What date did the reaction occur on? =>no further information is available.Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? if so, please clarify.=>no further information is available.What is the most current patient status? =>no further information is available.Can you identify the lot number of the product that was used? =>no further information is available.Please provide the following patient demographic information, if available: age, gender, weight, bmi at the time of index procedure? =>no further information is available.What are were the diagnosis and indication for the index surgical procedure? =>no.Further information is available.Please provide any relevant patient history: patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates.=>no further information is available.Was there any intraoperative concurrent use of other products? =>no further information is available.What was the intended use of the surgicel? was it used to address active bleeding or used prophylactically? =>no further information is available.Where was the surgicel used (on what tissue)? =>no further information is available.How much surgicel was used during the procedure? =>no further information is available.Was the surgicel product left in place? was the excess irrigated and removed? =>no further information is available.What were current symptoms following the index surgical procedure? onset date? =>no further information is available.Were cultures performed? if yes, what were the results? =>no further information is available.What is physician¿s opinion as to the etiology of or contributing factors to this event? =>no further information is available.Was there an alleged deficiency of the surgicel that contributed to the patient¿s post-operative infection? =>no further information is available.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported that a patient underwent an unknown procedure on an unknown date and absorbable hemostat was used.After the procedure a post-operative infection occurred.Additional information was requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGICEL POWDER USA - ABSORBABLE HEMOSTATIC PWDR
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km. 8.3
san lorenzo 00754
*   00754
Manufacturer Contact
elba bello
p.o. box 151, route 22 west
somerville, NJ 08876
9082183429
MDR Report Key10952310
MDR Text Key219896393
Report Number2210968-2020-09592
Device Sequence Number1
Product Code LMG
UDI-Device Identifier10705031237506
UDI-Public10705031237506
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
N12159
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 11/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number3013SP
Device Catalogue Number3013SP
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/10/2020
Initial Date FDA Received12/05/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-